Tower Research Capital LLC (Trc) Rocket Pharmaceuticals, Inc. Transaction History

Tower Research Capital LLC (Trc)

$4.87 Billion
Q4 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 34,187 shares of RCKT stock, worth $259,479. This represents 0.01% of its overall portfolio holdings.

Number of Shares

34,187

Previous 6,958 391.33%

Holding current value

$259,479

Previous $128,000 235.16%

% of portfolio

0.01%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$11.35 - $18.82 $309,049 - $512,449	27,229 Added 391.33%	34,187 $429,000
Q3 2024 Nov 14, 2024	SELL	$17.6 - $25.88 $134,587 - $197,904	-7,647 Reduced 52.36%	6,958 $128,000
Q2 2024 Aug 13, 2024	BUY	$20.66 - $26.72 $280,790 - $363,151	13,591 Added 1340.34%	14,605 $314,000
Q1 2024 May 15, 2024	SELL	$26.16 - $30.74 $66,524 - $78,171	-2,543 Reduced 71.49%	1,014 $27,000
Q4 2023 Feb 13, 2024	BUY	$16.78 - $31.94 $30,690 - $58,418	1,829 Added 105.84%	3,557 $106,000
Q3 2023 Nov 14, 2023	SELL	$15.07 - $24.05 $70,618 - $112,698	-4,686 Reduced 73.06%	1,728 $35,000
Q2 2023 Aug 14, 2023	BUY	$16.59 - $23.6 $56,289 - $80,074	3,393 Added 112.31%	6,414 $127,000
Q1 2023 May 09, 2023	SELL	$15.79 - $22.6 $15,000 - $21,470	-950 Reduced 23.92%	3,021 $52,000
Q4 2022 Feb 10, 2023	SELL	$15.5 - $22.76 $105,245 - $154,540	-6,790 Reduced 63.1%	3,971 $78,000
Q3 2022 Nov 10, 2022	BUY	$12.37 - $18.41 $84,709 - $126,071	6,848 Added 175.01%	10,761 $171,000
Q2 2022 Aug 15, 2022	SELL	$7.96 - $16.64 $73,247 - $153,121	-9,202 Reduced 70.16%	3,913 $54,000
Q1 2022 May 12, 2022	BUY	$13.16 - $23.68 $33,242 - $59,815	2,526 Added 23.85%	13,115 $208,000
Q4 2021 Feb 14, 2022	BUY	$21.52 - $36.02 $41,705 - $69,806	1,938 Added 22.4%	10,589 $231,000
Q3 2021 Nov 15, 2021	BUY	$27.42 - $48.97 $149,219 - $266,494	5,442 Added 169.59%	8,651 $259,000
Q2 2021 Aug 16, 2021	BUY	$39.41 - $47.25 $41,380 - $49,612	1,050 Added 48.63%	3,209 $142,000
Q1 2021 May 17, 2021	SELL	$43.34 - $65.91 $12,395 - $18,850	-286 Reduced 11.7%	2,159 $96,000
Q4 2020 Feb 16, 2021	SELL	$23.3 - $59.57 $17,777 - $45,451	-763 Reduced 23.78%	2,445 $134,000
Q3 2020 Nov 16, 2020	SELL	$20.5 - $28.59 $115,825 - $161,533	-5,650 Reduced 63.78%	3,208 $74,000
Q2 2020 Aug 13, 2020	BUY	$13.32 - $22.61 $117,988 - $200,279	8,858 New	8,858 $185,000
Q4 2019 Feb 07, 2020	SELL	$11.07 - $24.23 $47,047 - $102,977	-4,250 Closed	0 $0
Q3 2019 Nov 05, 2019	BUY	$10.85 - $14.78 $42,293 - $57,612	3,898 Added 1107.39%	4,250 $50,000
Q2 2019 Aug 13, 2019	BUY	$15.0 - $19.81 $5,280 - $6,973	352 New	352 $5,000
Q4 2018 Feb 14, 2019	SELL	$11.21 - $23.53 $224 - $470	-20 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$18.5 - $25.49 $370 - $509	20 New	20 $0
Q2 2018 Aug 15, 2018	SELL	$14.58 - $23.0 $9,506 - $14,996	-652 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$11.68 - $19.19 $7,615 - $12,511	652 New	652 $12,000

Others Institutions Holding RCKT

# of Institutions

244

Shares Held

94.5M

Call Options Held

262K

Put Options Held

159K

View Full List

About ROCKET PHARMACEUTICALS, INC.

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $574M
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

More about RCKT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Rocket Pharmaceuticals, Inc. Transaction History